Zobrazeno 1 - 10
of 69
pro vyhledávání: '"Wen-Rong Lie"'
Autor:
Zach S. Templeton, Wen-Rong Lie, Weiqi Wang, Yael Rosenberg-Hasson, Rajiv V. Alluri, John S. Tamaresis, Michael H. Bachmann, Kitty Lee, William J. Maloney, Christopher H. Contag, Bonnie L. King
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 17, Iss 12, Pp 849-861 (2015)
BACKGROUND/OBJECTIVES: Bone is a preferred site of breast cancer metastasis, suggesting the presence of tissue-specific features that attract and promote the outgrowth of breast cancer cells. We sought to identify parameters of human bone tissue asso
Externí odkaz:
https://doaj.org/article/3adf2171ed224d0584acf7772b111340
Autor:
Francesca Faustini, Helena Idborg, Enrico Fuzzi, Anders Larsson, Wen-Rong Lie, Sven Pötzsch, Shinji L Okitsu, Elisabet Svenungsson, Iva Gunnarsson
Publikováno v:
Lupus. 32:252-262
Background Lupus nephritis (LN) is a major and severe organ involvement in systemic lupus erythematosus (SLE), whose diagnosis and treatment necessitate to perform kidney biopsy, which is an invasive procedure. Non-invasive urine biomarkers are an ac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d244004afb521096b1d588b8ee46316
https://doi.org/10.1177/09612033221145534
https://doi.org/10.1177/09612033221145534
Publikováno v:
Cancer Research. 83:6380-6380
Immune checkpoint proteins are key regulators of the immune system and potential drug targets for cancer immunotherapy. Cancer immunotherapy targeting immune checkpoint, like programmed cell death protein-1 (PD-1) and programmed cell death ligand 1 (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c637d7200f98cf9e706554f23bfafff0
https://doi.org/10.1158/1538-7445.am2023-6380
https://doi.org/10.1158/1538-7445.am2023-6380
Autor:
Wen-Rong Lie, Ryan Bucktrout, Sanjukta Chakraborty, Andrea Orlando, Inna Serganova, Christine Kornmeier, James Hoberg, Roberta Zappasodi
Publikováno v:
Cancer Research. 83:6381-6381
Immune checkpoint proteins are key regulators of the immune system and drug targets of cancer immunotherapy. Immune checkpoint molecules have been found on the cell surface of various tumor cells and immune cells as immune activating or inhibitory re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c3c2bf8c96cf74d6bd0b18296250b353
https://doi.org/10.1158/1538-7445.am2023-6381
https://doi.org/10.1158/1538-7445.am2023-6381
Autor:
Melissa M. Berrien-Elliott, Jennifer A. Foltz, David A. Russler-Germain, Carly C. Neal, Jennifer Tran, Margery Gang, Pamela Wong, Bryan Fisk, Celia C. Cubitt, Nancy D. Marin, Alice Y. Zhou, Miriam T. Jacobs, Mark Foster, Timothy Schappe, Ethan McClain, Samantha Kersting-Schadek, Sweta Desai, Patrick Pence, Michelle Becker-Hapak, Jeremy Eisele, Matthew Mosior, Lynne Marsala, Obi L. Griffith, Malachi Griffith, Saad M. Khan, David H. Spencer, John F. DiPersio, Rizwan Romee, Geoffrey L. Uy, Camille N. Abboud, Armin Ghobadi, Peter Westervelt, Keith Stockerl-Goldstein, Mark A. Schroeder, Fei Wan, Wen-Rong Lie, Patrick Soon-Shiong, Allegra A. Petti, Amanda F. Cashen, Todd A. Fehniger
Publikováno v:
Sci Transl Med
Natural killer (NK) cells are innate lymphoid cells that eliminate cancer cells, produce cytokines, and are being investigated as a nascent cellular immunotherapy. Impaired NK cell function, expansion, and persistence remain key challenges for optima
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e3d5b150b9fb46a2a7f0c16ecb5e95ee
https://europepmc.org/articles/PMC9210521/
https://europepmc.org/articles/PMC9210521/
Autor:
Jeffrey J. Bednarski, Clare Zimmerman, Melissa M. Berrien-Elliott, Jennifer A. Foltz, Michelle Becker-Hapak, Carly C. Neal, Mark Foster, Timothy Schappe, Ethan McClain, Patrick P. Pence, Sweta Desai, Samantha Kersting-Schadek, Pamela Wong, David A. Russler-Germain, Bryan Fisk, Wen-Rong Lie, Jeremy Eisele, Stephanie Hyde, Sima T. Bhatt, Obi L. Griffith, Malachi Griffith, Allegra A. Petti, Amanda F. Cashen, Todd A. Fehniger
Publikováno v:
Blood. 139(11)
Pediatric and young adult (YA) patients with acute myeloid leukemia (AML) who relapse after allogeneic hematopoietic cell transplantation (HCT) have an extremely poor prognosis. Standard salvage chemotherapy and donor lymphocyte infusions (DLIs) have
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e9efaab635be9bfc8a2aaaeb83827448
https://pubmed.ncbi.nlm.nih.gov/35298605
https://pubmed.ncbi.nlm.nih.gov/35298605
Autor:
Pfeiffer, Thomas, Zimmerman, Clare, Berrien-Elliott, Melissa M, Foltz, Jennifer, Becker-Hapak, Michelle, Neal, Carly, Foster, Mark, Schappe, Timothy, McClain, Ethan, Pence, Patrick, Desai, Sweta, Wong, Pamela, Russler-Germain, David, Fisk, Bryan, Wen-Rong, Lie, Eisele, Jeremy, Hyde, Stephanie, Bhatt, Sima, Griffith, Obi, Griffith, Malachi, Rueve, Joseph, Pureti, Sushanth, Cashen, Amanda, Bednarski, Jeffrey J, Fehniger, Todd A
Publikováno v:
In Transplantation and Cellular Therapy February 2024 30(2) Supplement:S12-S12
Publikováno v:
Cancer Research. 82:5080-5080
Immune checkpoint proteins are key regulators of the immune system and drug targets of cancer immunotherapy. There is extensive literature on the use of various types of mouse models for biomarker discovery and drug testing. Only a few studies have e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::469c406ebfea6eb56100e4f5648533a5
https://doi.org/10.1158/1538-7445.am2022-5080
https://doi.org/10.1158/1538-7445.am2022-5080
Autor:
Wen-Rong Lie, Christine Kornmeier, Sasha Williams, Justin Pfeifer, Munmun Banerjee, James Hoberg
Publikováno v:
The Journal of Immunology. 208:116.20-116.20
Immune checkpoint protein research plays a significant role in improving antitumor immune response as well as achieving a deeper understanding of the immune system and the disease states of inflammation, sepsis, and autoimmunity. Various mouse models
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::15c701d33881ec36a030ebe5d660f356
https://doi.org/10.4049/jimmunol.208.supp.116.20
https://doi.org/10.4049/jimmunol.208.supp.116.20
Autor:
Marta Batus, Sanjib Basu, Hita Moudgalya, Jeffrey A. Borgia, Wen Rong Lie, Imad Tarhoni, Mary J. Fidler, Philip Bonomi, Danielle Pepin
Publikováno v:
Cancer Research. 81:1621-1621
Introduction: Immune checkpoint inhibitor (ICI) therapy has shown remarkable benefits in treating non-small-cell lung cancer (NSCLC). However, progress beyond PD-L1 expression has not yielded biomarkers that can better select responders to ICI. This
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6f532acd14f304bb2a24f9a92252a003
https://doi.org/10.1158/1538-7445.am2021-1621
https://doi.org/10.1158/1538-7445.am2021-1621